A prostate cancer diagnosis does not automatically mean surgery or immediate treatment. The right prostate cancer treatment depends on several factors, including the cancer’s stage, Grade Group, PSA level, whether it has spread, your overall health, life expectancy, and your personal preferences. Treatment can range from active surveillance for some low-risk cancers to surgery, radiation, hormone therapy, chemotherapy, targeted medicines, or radioligand therapy for more advanced disease.
Because prostate cancer behaves differently from one person to another, there is no single “best” treatment for everyone. The goal is to match the treatment intensity to the cancer while considering quality of life and possible side effects.
Medical note: This article provides general educational information and is not a substitute for advice from a urologist, radiation oncologist, medical oncologist, or other qualified healthcare professional.
What Is Prostate Cancer Treatment?
Prostate cancer treatment refers to medical approaches used to control, eliminate, or manage cancer that develops in the prostate gland.
Doctors may use one treatment or combine several approaches. Common options include active surveillance, surgery, radiation therapy, hormone therapy, chemotherapy, targeted therapy, immunotherapy, and treatments directed at cancer that has spread to the bones or other parts of the body.
The first question is usually not simply, “Which treatment is best?” Instead, doctors determine how aggressive the cancer is and how far it has spread.
How Doctors Choose Prostate Cancer Treatment
Several pieces of information help create an individualized treatment plan.
PSA Level
Prostate-specific antigen (PSA) is a protein measured through a blood test. PSA levels are considered alongside biopsy findings, imaging, and other clinical information rather than being used alone to determine treatment.
Gleason Score and Grade Group
A prostate biopsy allows a pathologist to examine cancer cells and assess how abnormal they look.
The Gleason system and Grade Group help estimate how aggressively the cancer may behave. Higher-grade cancers generally have a greater likelihood of growing and spreading.
Cancer Stage
Staging determines whether the cancer is confined to the prostate, has extended nearby, or has spread to distant locations. The TNM system evaluates the primary tumor, lymph nodes, and distant metastases.
Overall Health and Personal Preferences
Age, other medical conditions, life expectancy, urinary function, sexual health, treatment goals, and personal preferences can all influence the decision.
For localized disease in particular, several treatments may be reasonable options, so discussing their benefits and risks with your care team is important.
Prostate Cancer Treatment by Stage and Risk
The treatment pathway can look very different depending on whether cancer is low-risk, high-risk, or metastatic.
| Risk or stage | Common treatment approaches | Main consideration |
| Very-low/low risk | Active surveillance, selected surgery or radiation | Avoiding unnecessary treatment side effects |
| Favorable intermediate risk | Active surveillance in selected patients, surgery, radiation | Balancing cancer control with quality of life |
| Unfavorable intermediate risk | Surgery or radiation plus hormone therapy in appropriate patients | Higher risk of progression |
| High/very-high risk | Radiation plus hormone therapy or selected surgery-based approaches | Often requires more intensive treatment |
| Metastatic disease | Systemic hormone-based treatment, chemotherapy, targeted or radioligand therapy in appropriate patients | Long-term cancer control and quality of life |
| Recurrent disease | Treatment based on previous therapy, location of recurrence, imaging, and tumor biology | Selecting an appropriate next-line treatment |
Treatment recommendations vary according to individual circumstances and evolving clinical guidance.
Active Surveillance for Prostate Cancer
Active surveillance is an important option for some men with lower-risk prostate cancer.
Instead of treating the cancer immediately, doctors monitor it closely with scheduled tests. Monitoring can involve PSA testing, examinations, imaging, and repeat biopsies when appropriate. If there are signs that the cancer is becoming more aggressive, definitive treatment can be considered.
Why Choose Active Surveillance?
The main advantage is avoiding or delaying treatment-related complications when the cancer has a low likelihood of causing harm in the near term.
For example, surgery and radiation can affect urinary, bowel, and sexual function. Active surveillance may allow an appropriate patient to maintain quality of life while keeping the option of treatment if the cancer changes.
Active surveillance is different from simply ignoring cancer. It involves a structured monitoring plan.
Surgery for Prostate Cancer
Radical prostatectomy involves removing the prostate gland and surrounding tissues, with nearby lymph nodes sometimes removed depending on the situation.
It can be used with curative intent for selected men whose cancer has not spread extensively.
Modern surgical approaches can include minimally invasive and robotic techniques.
Possible Benefits and Risks
Surgery physically removes the prostate and allows the removed tissue to be examined by a pathologist.
However, potential side effects can include:
- Urinary leakage or incontinence
- Erectile dysfunction
- Changes in ejaculation and fertility
- Bleeding or infection
- Recovery-related discomfort
The likelihood and severity of side effects vary between individuals.
Radiation Therapy
Radiation therapy uses high-energy radiation to damage cancer cells.
External-beam radiation therapy directs radiation toward the prostate and surrounding treatment area. Another approach, called brachytherapy, places radioactive material in or near the prostate.
Radiation can be used as an alternative to surgery for selected localized cancers and may also be combined with hormone therapy for higher-risk disease.
Possible side effects include urinary irritation, bowel changes, fatigue, and sexual problems. Some effects can develop during treatment, while others may occur later.
Hormone Therapy for Prostate Cancer
Hormone therapy, also called androgen deprivation therapy (ADT), reduces or blocks male hormones that can help prostate cancer grow.
It is particularly important in advanced disease and may be combined with radiation or other systemic treatments depending on the cancer’s characteristics.
Potential side effects include:
- Hot flashes
- Reduced libido
- Erectile difficulties
- Fatigue
- Changes in body composition
- Bone loss
- Metabolic changes
Doctors may monitor bone health and other aspects of long-term wellbeing during hormone treatment.
Chemotherapy and Advanced Prostate Cancer Treatment
Chemotherapy uses medicines that travel throughout the body to destroy or slow cancer cells. It may be used for selected patients with advanced prostate cancer, sometimes in combination with hormone-based treatment.
For advanced or recurrent cancer, treatment may also include targeted medicines, immunotherapy, additional hormone-based treatments, or radiopharmaceutical approaches depending on the patient’s tumor characteristics and previous treatments.
Targeted Therapy and Genetic Testing
Modern prostate cancer care increasingly considers the biology of the tumor.
Some advanced prostate cancers contain changes in genes involved in DNA repair. In appropriate patients, identifying these changes can help doctors determine whether targeted treatments such as PARP inhibitors may be useful.
This is one reason genetic and genomic testing may be discussed, particularly for men with advanced or higher-risk disease.
The important point is that targeted therapy is not appropriate for every prostate cancer patient. Treatment depends on the specific genetic alteration, cancer stage, previous treatments, and approved indications.
PSMA Imaging and Radioligand Therapy
Prostate-specific membrane antigen (PSMA) has become important in both prostate cancer imaging and treatment.
PSMA PET imaging can help identify prostate cancer cells that express PSMA. In selected advanced cases, PSMA-targeted radioligand therapy can deliver radiation directly to cancer cells.
For example, the FDA expanded the approved use of lutetium Lu 177 vipivotide tetraxetan (Pluvicto) in March 2025 for certain adults with PSMA-positive metastatic castration-resistant prostate cancer after androgen receptor pathway inhibitor treatment. Patient selection involves PSMA PET imaging.
These therapies represent an important area of modern prostate cancer treatment, but eligibility depends on specific clinical criteria.
What Happens After Prostate Cancer Treatment?
Treatment doesn’t necessarily end when surgery, radiation, or medication is completed.
Follow-up commonly includes monitoring PSA and evaluating symptoms, treatment effects, and overall health. The follow-up plan depends on the treatment received and the individual’s risk of recurrence.
Some men experience urinary incontinence, erectile dysfunction, bowel changes, fatigue, or hormonal effects after treatment.
Managing Treatment Side Effects
Recovery may involve:
- Pelvic-floor physical therapy
- Bladder training
- Sexual rehabilitation
- Medication for specific symptoms
- Exercise and strength training when medically appropriate
- Bone-health monitoring during long-term hormone therapy
- Emotional and psychological support
A side effect should not simply be accepted as something you must live with. Tell your healthcare team about persistent symptoms because supportive treatments may be available.
What If Prostate Cancer Comes Back?
Prostate cancer can recur after initial treatment.
Doctors may identify recurrence through rising PSA levels, imaging, symptoms, or other findings. The next treatment depends heavily on what treatment was previously used and where the cancer is located.
Possible approaches can include additional radiation, hormone therapy, systemic medicines, targeted treatments, chemotherapy, radiopharmaceutical therapy, or clinical trials.
This is another situation where individualized treatment planning is essential.
Clinical Trials and New Prostate Cancer Treatments
Clinical trials can provide access to treatments that are still being studied.
Research continues into new combinations of hormone therapies, targeted medicines, radioligand treatments, immunotherapies, imaging techniques, and other approaches.
A clinical trial isn’t necessarily a “last resort.” Depending on the cancer and eligibility criteria, trials may be considered at different points during treatment.
Ask your cancer care team whether a clinical trial is appropriate for your particular diagnosis.
Questions to Ask Your Doctor
Before deciding on treatment, consider asking:
- What is my Grade Group and PSA level?
- What stage and risk group is my prostate cancer?
- Has the cancer spread outside the prostate?
- Do I qualify for active surveillance?
- What are the benefits and risks of surgery?
- How does radiation compare with surgery in my case?
- Would hormone therapy be recommended?
- Should I have genetic or genomic testing?
- What side effects are most likely with each option?
- Are there clinical trials appropriate for me?
Writing down your questions and bringing a family member or trusted person to appointments can make complicated treatment discussions easier to follow.
Conclusion
The best prostate cancer treatment depends on the individual cancer, not simply the diagnosis. Active surveillance can be appropriate for some lower-risk cancers, while surgery or radiation may be considered for localized disease. Higher-risk and metastatic cancers may require combinations of hormone therapy, chemotherapy, targeted medicines, radiation, or newer treatments such as PSMA-directed radioligand therapy.
The most useful next step is to understand your PSA, Grade Group, stage, risk category, treatment goals, and potential side effects. Use that information to have a detailed conversation with your cancer care team and consider a second opinion when appropriate.
Frequently Asked Questions
What is the most effective prostate cancer treatment?
There is no single treatment that is best for everyone. The appropriate approach depends on cancer stage, Grade Group, PSA, overall health, life expectancy, previous treatment, and personal preferences.
Can prostate cancer be cured?
Some localized prostate cancers can be treated with curative intent, particularly when the cancer has not spread outside the prostate or nearby tissues. Advanced metastatic prostate cancer is generally managed as a chronic disease, with treatment focused on controlling cancer and maintaining quality of life.
Is surgery better than radiation for prostate cancer?
Neither is automatically better for every patient. Surgery and radiation can both be appropriate for selected localized cancers, but they have different treatment processes, risks, recovery patterns, and potential side effects.
Can prostate cancer be treated without surgery?
Yes. Depending on the cancer’s risk and stage, options can include active surveillance, radiation therapy, hormone therapy, systemic medicines, and other approaches.
What is the newest treatment for prostate cancer?
New treatments continue to emerge, including targeted therapies and PSMA-directed radioligand therapies. However, a newer treatment is not automatically better or appropriate for every patient. Eligibility depends on cancer characteristics and previous treatment.
What happens if prostate cancer spreads?
When prostate cancer spreads, treatment usually focuses on controlling the disease throughout the body. Hormone-based treatment is a major component, and chemotherapy, targeted therapy, radiopharmaceutical treatment, radiation, or other systemic approaches may be considered depending on the situation.
Can prostate cancer return after treatment?
Yes. Recurrence can occur after initial treatment. PSA monitoring and other follow-up assessments help doctors detect possible recurrence and determine whether additional treatment is needed.